2021 Form 10-K Financial Statement

#000162828022005958 Filed on March 14, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $115.8M $135.0M $47.02M
YoY Change 146.24% 217.04% 156.13%
Cost Of Revenue $111.2M $34.90M $118.9M
YoY Change -6.47% 12.4% -11.78%
Gross Profit $4.575M $16.17M $1.041M
YoY Change 339.54% 40.14% 10.21%
Gross Profit Margin 3.95% 11.98% 2.21%
Selling, General & Admin $17.73M $26.14M $8.117M
YoY Change 118.45% 293.15% 21.93%
% of Gross Profit 387.64% 161.66% 779.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $594.1K $1.850M $529.9K
YoY Change 12.11% 0.0% 14.93%
% of Gross Profit 12.99% 11.44% 50.92%
Operating Expenses $19.96M $26.14M $8.189M
YoY Change 143.79% 207.94% 23.01%
Operating Profit -$15.39M -$11.87M -$7.148M
YoY Change 115.28% -489.11% 25.13%
Interest Expense $3.487M -$450.0K $409.8K
YoY Change 750.91% -71.34% -24.28%
% of Operating Profit
Other Income/Expense, Net -$15.02M $1.105M
YoY Change -1459.4% -704.61%
Pretax Income -$30.40M -$2.940M -$6.044M
YoY Change 403.06% -314.6% 2.52%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$18.36M -$3.390M -$12.04M
YoY Change 52.57% -337.06% 138.41%
Net Earnings / Revenue -15.86% -2.51% -25.6%
Basic Earnings Per Share -$0.36 -$0.67
Diluted Earnings Per Share -$0.36 -$74.41K -$0.67
COMMON SHARES
Basic Shares Outstanding 56.30M shares 45.55M shares 45.51M shares
Diluted Shares Outstanding 56.30M shares 45.51M shares

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.13M $10.90M $10.90M
YoY Change 231.47% 165.85% 165.85%
Cash & Equivalents $36.13M $10.90M $10.90M
Short-Term Investments
Other Short-Term Assets $189.0M $3.300M $3.300M
YoY Change 5626.94% -28.26% -28.26%
Inventory $3.736M $1.458M $4.400M
Prepaid Expenses $2.589M
Receivables $5.297M $5.212M $11.10M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $234.2M $29.79M $29.80M
YoY Change 685.74% 8.68% 8.76%
LONG-TERM ASSETS
Property, Plant & Equipment $16.78M $13.28M $81.30M
YoY Change -79.36% -70.34% 0.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.77M $1.009M $1.600M
YoY Change 823.23% 19.98% 100.0%
Total Long-Term Assets $31.91M $92.31M $92.30M
YoY Change -65.43% -1.11% -1.18%
TOTAL ASSETS
Total Short-Term Assets $234.2M $29.79M $29.80M
Total Long-Term Assets $31.91M $92.31M $92.30M
Total Assets $266.1M $122.1M $122.1M
YoY Change 117.9% 1.11% 1.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.216M $3.311M $10.50M
YoY Change -59.84% -56.55% 38.16%
Accrued Expenses $4.577M $1.649M $7.700M
YoY Change -40.55% -67.13% -29.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $100.0K $100.0K
YoY Change -100.0% -96.95% -96.97%
Long-Term Debt Due $2.715M $6.712M $4.900M
YoY Change -44.58% 232.7% 122.73%
Total Short-Term Liabilities $49.15M $26.19M $23.90M
YoY Change 105.66% 5.64% -3.63%
LONG-TERM LIABILITIES
Long-Term Debt $64.13M $5.637M $8.900M
YoY Change 620.57% -54.66% -31.54%
Other Long-Term Liabilities $79.26M $28.00M $28.00M
YoY Change 183.08% -11.67% -11.67%
Total Long-Term Liabilities $143.4M $5.637M $36.90M
YoY Change 288.6% -54.66% -17.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $49.15M $26.19M $23.90M
Total Long-Term Liabilities $143.4M $5.637M $36.90M
Total Liabilities $238.0M $60.81M $93.70M
YoY Change 153.99% -12.52% 25.44%
SHAREHOLDERS EQUITY
Retained Earnings -$90.01M
YoY Change 51.92%
Common Stock $45.56K
YoY Change 4.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.07M $4.607M $28.40M
YoY Change
Total Liabilities & Shareholders Equity $266.1M $122.1M $122.1M
YoY Change 117.9% 1.11% 1.08%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$18.36M -$3.390M -$12.04M
YoY Change 52.57% -337.06% 138.41%
Depreciation, Depletion And Amortization $594.1K $1.850M $529.9K
YoY Change 12.11% 0.0% 14.93%
Cash From Operating Activities $9.683M -$1.430M -$76.40K
YoY Change -12774.19% -125.86% -103.09%
INVESTING ACTIVITIES
Capital Expenditures $1.145M -$2.470M $937.3K
YoY Change 22.14% 333.33% 336.05%
Acquisitions -$2.058K $1.823M
YoY Change -100.11%
Other Investing Activities -$16.68M $40.00K -$1.750M
YoY Change 853.08% -71.43% -860.87%
Cash From Investing Activities -$17.82M -$2.420M -$8.433M
YoY Change 111.35% 462.79% 132.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 133.8M -800.0K $15.31M
YoY Change 774.04% -75.83% 511.41%
NET CHANGE
Cash From Operating Activities 9.683M -1.430M -$76.40K
Cash From Investing Activities -17.82M -2.420M -$8.433M
Cash From Financing Activities 133.8M -800.0K $15.31M
Net Change In Cash $125.6M -4.650M $6.795M
YoY Change 1748.79% -359.78% 403.36%
FREE CASH FLOW
Cash From Operating Activities $9.683M -$1.430M -$76.40K
Capital Expenditures $1.145M -$2.470M $937.3K
Free Cash Flow $8.538M $1.040M -$1.014M
YoY Change -942.27% -82.95% -144.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000890447
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-11476
CY2021 dei Entity Registrant Name
EntityRegistrantName
VERTEX ENERGY, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3439569
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1331 Gemini Street
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 250
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77058
CY2021 dei City Area Code
CityAreaCode
866
CY2021 dei Local Phone Number
LocalPhoneNumber
660-8156
CY2021 dei Security12b Title
Security12bTitle
Common Stock,$0.001 Par Value Per Share
CY2021 dei Trading Symbol
TradingSymbol
VTNR
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
685088839 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63352411 shares
CY2021 dei Auditor Firm
AuditorFirmId
298
CY2021 dei Auditor Name
AuditorName
Ham, Langston & Brezina, L.L.P.
CY2021 dei Auditor Location
AuditorLocation
Houston, Texas
CY2021 dei Auditor Name
AuditorName
Ham, Langston & Brezina, L.L.P.
CY2021 dei Auditor Location
AuditorLocation
Houston, Texas
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36129941 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10895044 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100496998 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100125 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5296867 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5211621 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
3735878 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1458288 USD
CY2021Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
95980 USD
CY2020Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
0 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4279732 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2588887 USD
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
84116152 USD
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
9531423 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
234151548 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
29785388 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13811835 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14848813 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2045241 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1573025 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11766594 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13275788 USD
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
18100 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5011454 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4734497 USD
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
358881 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
466546 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14771642 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1008733 USD
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 USD
CY2020Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
72810906 USD
CY2021Q4 us-gaap Assets
Assets
266060119 USD
CY2020Q4 us-gaap Assets
Assets
122099958 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4216275 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3310992 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3617902 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1648964 USD
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
606550 USD
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
302166 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
271099 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
959573 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
783747 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2413295 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6711708 USD
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
133446 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
94214 USD
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
37644312 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
12634231 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49153523 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26194951 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
114480 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5636957 USD
CY2021Q4 us-gaap Senior Notes
SeniorNotes
64015929 USD
CY2020Q4 us-gaap Senior Notes
SeniorNotes
0 USD
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
617679 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4051881 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3950750 USD
CY2021Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
75210525 USD
CY2020Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
330412 USD
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 USD
CY2020Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
24078274 USD
CY2021Q4 us-gaap Liabilities
Liabilities
192546338 USD
CY2020Q4 us-gaap Liabilities
Liabilities
60809023 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
43446684 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
31611674 USD
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
43446684 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
55366186 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63287965 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63287965 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45554841 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45554841 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
63288 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
45555 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138620254 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94569674 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110614035 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90008778 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
28069893 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
4606871 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1997204 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
1317878 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30067097 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5924749 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
266060119 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122099958 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115781375 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47019043 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18357575 USD
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
110720368 USD
CY2020 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
45520114 USD
CY2019 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
16952135 USD
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
486428 USD
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
458155 USD
CY2019 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
461110 USD
CY2021 us-gaap Gross Profit
GrossProfit
4574579 USD
CY2020 us-gaap Gross Profit
GrossProfit
1040774 USD
CY2019 us-gaap Gross Profit
GrossProfit
944330 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17732690 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8117429 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6657178 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2123703 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
107664 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
71776 USD
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
19964057 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
8189205 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
6657178 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-15389478 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-7148431 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-5712848 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
4222000 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
101 USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
920197 USD
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-64278 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-124515 USD
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-74111 USD
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15685355 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1638804 USD
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
487524 USD
CY2021 us-gaap Interest Expense
InterestExpense
3487448 USD
CY2020 us-gaap Interest Expense
InterestExpense
409849 USD
CY2019 us-gaap Interest Expense
InterestExpense
541250 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15015081 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1104541 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-182688 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30404559 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6043890 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5895536 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-30404559 USD
CY2020 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6043890 USD
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5895536 USD
CY2021Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
22743382 USD
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-5352285 USD
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
409983 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-7661177 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-11396175 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-5485553 USD
CY2021 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
206804 USD
CY2020 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
363732 USD
CY2019 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-436974 USD
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
10495772 USD
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
276208 USD
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-18363753 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-12036115 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-5048579 USD
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1992360 USD
CY2020 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
15135242 USD
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2279371 USD
CY2021 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
507282 USD
CY2020 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
1687850 USD
CY2019 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
2489722 USD
CY2021 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
-258138 USD
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1903057 USD
CY2019 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
1627956 USD
CY2021 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-32852867 USD
CY2020 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-25133771 USD
CY2019 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-11855611 USD
CY2021 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
12247610 USD
CY2020 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-5628493 USD
CY2019 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
409983 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20605257 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30762264 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11445628 USD
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.58
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.55
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.29
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.22
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.12
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.58
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.55
CY2019 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.29
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.22
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.12
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56302716 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45509470 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45509470 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40988946 shares
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40988946 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56302716 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45509470 shares
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40988946 shares
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28809044 USD
CY2019 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
285534 USD
CY2019 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1627956 USD
CY2019 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
2489722 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
642840 USD
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7075 USD
CY2019 vtnr Conversionof Preferred C Stockto Common Value
ConversionofPreferredCStocktoCommonValue
970809 USD
CY2019 vtnr Conversionof Preferred B1 Stockto Common Value
ConversionofPreferredB1StocktoCommonValue
2562015 USD
CY2019 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
2279371 USD
CY2019 vtnr Stock And Warrants Issued During Period Value Common Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValueCommonStockAndWarrants
2216711 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-5485553 USD
CY2019 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
-61668 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23102026 USD
CY2020 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1903057 USD
CY2020 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1687850 USD
CY2020 vtnr Conversionof Preferred B1 Stockto Common Value
ConversionofPreferredB1StocktoCommonValue
3368474 USD
CY2020 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
15135242 USD
CY2020 vtnr Conversionof Preferred C Stockto Common Value
ConversionofPreferredCStocktoCommonValue
9091068 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-11396175 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656111 USD
CY2020 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-71171 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-11396175 USD
CY2020 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
99435 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5924749 USD
CY2021 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
372183 USD
CY2021 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
507282 USD
CY2021 vtnr Conversionof Preferred B1 Stockto Common Value
ConversionofPreferredB1StocktoCommonValue
12046441 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2189691 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
862564 USD
CY2021 vtnr Stock Issued During Period Value Conversion Of Series A Preferred Stock To Common
StockIssuedDuringPeriodValueConversionOfSeriesAPreferredStockToCommon
0 USD
CY2021 vtnr Noncontrolling Interest Increase From Contribution To Noncontrolling Interest Holders
NoncontrollingInterestIncreaseFromContributionToNoncontrollingInterestHolders
11231 USD
CY2021 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
169368 USD
CY2021 us-gaap Increase In Carrying Amount Of Redeemable Preferred Stock
IncreaseInCarryingAmountOfRedeemablePreferredStock
1992360 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-7661177 USD
CY2021 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
9842651 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30067097 USD
CY2021 us-gaap Profit Loss
ProfitLoss
-7661177 USD
CY2019 us-gaap Profit Loss
ProfitLoss
-5485553 USD
CY2021Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
22743382 USD
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-5352285 USD
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
409983 USD
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-30404559 USD
CY2020 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-6043890 USD
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5895536 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
862564 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
656111 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
642840 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
594092 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
529931 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
461110 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
646910 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12176 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-267876 USD
CY2021 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-2257592 USD
CY2020 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
3476593 USD
CY2019 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-2458359 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4222000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
2436055 USD
CY2020 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-4253198 USD
CY2019 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
2841052 USD
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-64278 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-124515 USD
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-74111 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2123703 USD
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1231492 USD
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
47826 USD
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
573908 USD
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15685355 USD
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1638804 USD
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
487524 USD
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-15564 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
677786 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1384179 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-243947 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2245732 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-389010 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-567800 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1702576 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
19276 USD
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
422289 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
835914 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1651015 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-166121 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1967172 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-407150 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
470252 USD
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
100000 USD
CY2020 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
644060 USD
CY2019 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
222995 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15519636 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5950170 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3851582 USD
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0 USD
CY2020 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
49229 USD
CY2019 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
489093 USD
CY2021 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
13662910 USD
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 USD
CY2019 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 USD
CY2021 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
75168 USD
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
74965 USD
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
232020 USD
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-2058 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1822690 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1144787 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
937276 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
214945 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-14730471 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2734230 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-472018 USD
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-133446 USD
CY2020 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-3142784 USD
CY2019 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-568406 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
226431 USD
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
79790 USD
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6921846 USD
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7075 USD
CY2021 vtnr Proceeds From Issuance Of Common Stock And Warrant Exercises
ProceedsFromIssuanceOfCommonStockAndWarrantExercises
0 USD
CY2020 vtnr Proceeds From Issuance Of Common Stock And Warrant Exercises
ProceedsFromIssuanceOfCommonStockAndWarrantExercises
0 USD
CY2019 vtnr Proceeds From Issuance Of Common Stock And Warrant Exercises
ProceedsFromIssuanceOfCommonStockAndWarrantExercises
2216711 USD
CY2021 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
2260 USD
CY2020 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2019 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
169368 USD
CY2020 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2019 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
285534 USD
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
21000000 USD
CY2019 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3150000 USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
586612 USD
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
143830975 USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8217195 USD
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2809139 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15835707 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10366701 USD
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4660120 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
134029948 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15481279 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2589075 USD
CY2021 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
25202336 USD
CY2020 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
5227024 USD
CY2019 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
6324749 USD
CY2021 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-3093278 USD
CY2020 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-5052429 USD
CY2019 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-3154422 USD
CY2021 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-257129 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
2505852 USD
CY2020 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-176130 USD
CY2019 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-85808 USD
CY2021 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
21851929 USD
CY2020 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-1535 USD
CY2019 us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
3084519 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
125631770 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6795344 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1349994 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10995169 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4199825 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2849831 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136626939 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10995169 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4199825 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2273304 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1050741 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
-258138 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1903057 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1627956 USD
CY2021 vtnr Noncontrolling Interest Adjustment To Carrying Amount
NoncontrollingInterestAdjustmentToCarryingAmount
0 USD
CY2020 vtnr Noncontrolling Interest Adjustment To Carrying Amount
NoncontrollingInterestAdjustmentToCarryingAmount
9091068 USD
CY2019 vtnr Noncontrolling Interest Adjustment To Carrying Amount
NoncontrollingInterestAdjustmentToCarryingAmount
970809 USD
CY2021 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
507282 USD
CY2020 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
1687850 USD
CY2019 vtnr Preferred Stock Accretion Of Discount
PreferredStockAccretionOfDiscount
2489722 USD
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1992360 USD
CY2020 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
15135242 USD
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2279371 USD
CY2021 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1017638 USD
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
621000 USD
CY2021Q4 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
15 state
CY2021Q4 vtnr Working Capital
WorkingCapital
185000000 USD
CY2020Q4 vtnr Working Capital
WorkingCapital
3600000 USD
CY2021Q4 vtnr Increase In Working Capital Due To Restricted Escrow Account
IncreaseInWorkingCapitalDueToRestrictedEscrowAccount
100000000 USD
CY2021Q4 vtnr Increase In Working Capital Due To Current Assets Held For Sale
IncreaseInWorkingCapitalDueToCurrentAssetsHeldForSale
84000000 USD
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36129941 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10895044 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100496998 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100125 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
136626939 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10995169 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
100396873 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
999683 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
352775 USD
CY2020Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
21000000 USD
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Reclassification of Prior Year PresentationCertain prior period amounts have been reclassified to conform to current period presentation. These reclassifications had no effect on the reported results of operations, stockholders' equity or cash flows.
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. Any effects on the business, financial position or results of operations from revisions to these estimates are recorded in the period in which the facts that give rise to the revision become known.</span></div>Significant items subject to estimates and assumptions include the carrying amount and useful lives of property and equipment and intangible assets, impairment assessments, share-based compensation expense, and valuation allowances for accounts receivable, inventories, deferred tax assets, derivative liabilities, and redemption value of noncontrolling interest.
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020 us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
0 USD
CY2021 us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
0 USD
CY2019 us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
0 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115781375 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47019043 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18357575 USD
CY2021 vtnr Numberof Independent Directorsin Related Party Committee
NumberofIndependentDirectorsinRelatedPartyCommittee
2 director
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
742447 USD
CY2020 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
62185 USD
CY2020Q1 vtnr Adjustments To Retained Earnings Reclassification From Noncontrolling Interests
AdjustmentsToRetainedEarningsReclassificationFromNoncontrollingInterests
9091068 USD
CY2019 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
100683 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13811835 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14848813 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2045241 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1573025 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11766594 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13275788 USD
CY2021 us-gaap Depreciation
Depreciation
482808 USD
CY2020 us-gaap Depreciation
Depreciation
453811 USD
CY2019 us-gaap Depreciation
Depreciation
461110 USD
CY2020 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
15135242 USD
CY2021Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1000
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
78190691 USD
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
86452097 USD
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
261668500 USD
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
313789 USD
CY2020 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-690004 USD
CY2019 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-5724176 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107664 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71776 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
107664 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
107664 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
107664 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
35890 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
0 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
358882 USD
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6296550 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5564396 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
999683 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
352775 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5296867 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5211621 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2829942 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13370890 USD
CY2021Q4 vtnr Longterm Debtand Finance Lease Liability Year One
LongtermDebtandFinanceLeaseLiabilityYearOne
2715461 USD
CY2021Q4 vtnr Longterm Debtand Finance Lease Liability Due Year Two
LongtermDebtandFinanceLeaseLiabilityDueYearTwo
40174 USD
CY2021Q4 vtnr Long Term Debt And Finance Lease Liability Due Year Three
LongTermDebtAndFinanceLeaseLiabilityDueYearThree
17911 USD
CY2021Q4 vtnr Longterm Debtand Finance Lease Liability Due Year Four
LongtermDebtandFinanceLeaseLiabilityDueYearFour
1352 USD
CY2021Q4 vtnr Longterm Debtand Finance Lease Liability Due Year Five
LongtermDebtandFinanceLeaseLiabilityDueYearFive
1404 USD
CY2021Q4 vtnr Longterm Debtand Finance Lease Liability Due After Year Five
LongtermDebtandFinanceLeaseLiabilityDueAfterYearFive
53640 USD
CY2021Q4 vtnr Interest Payable Long Term Debt Due Year One
InterestPayableLongTermDebtDueYearOne
9687500 USD
CY2021Q4 vtnr Interest Payable Long Term Debt Due Year Two
InterestPayableLongTermDebtDueYearTwo
9687500 USD
CY2021Q4 vtnr Interest Payable Long Term Debt Due Year Three
InterestPayableLongTermDebtDueYearThree
9687500 USD
CY2021Q4 vtnr Interest Payable Long Term Debt Due Year Four
InterestPayableLongTermDebtDueYearFour
9687500 USD
CY2021Q4 vtnr Interest Payable Long Term Debt Due Year Five
InterestPayableLongTermDebtDueYearFive
9687500 USD
CY2021Q4 vtnr Interest Payable Long Term Debt Due After Year Five
InterestPayableLongTermDebtDueAfterYearFive
7272260 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3856000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
69000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
69000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-69000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-69000 USD
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2020 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2019 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2393000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1152000 USD
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-574000 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7000 USD
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
139000 USD
CY2021 vtnr Effective Income Tax Rate Reconciliation Change In Derivative Liability Amount
EffectiveIncomeTaxRateReconciliationChangeInDerivativeLiabilityAmount
2382000 USD
CY2020 vtnr Effective Income Tax Rate Reconciliation Change In Derivative Liability Amount
EffectiveIncomeTaxRateReconciliationChangeInDerivativeLiabilityAmount
-344000 USD
CY2019 vtnr Effective Income Tax Rate Reconciliation Change In Derivative Liability Amount
EffectiveIncomeTaxRateReconciliationChangeInDerivativeLiabilityAmount
102000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 USD
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1745000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
210000 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6570000 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
904000 USD
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1344000 USD
CY2021 vtnr Effective Income Tax Rate Reconciliation Paycheck Protection Program Loan Forgiveness
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramLoanForgiveness
-887000 USD
CY2020 vtnr Effective Income Tax Rate Reconciliation Paycheck Protection Program Loan Forgiveness
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramLoanForgiveness
0 USD
CY2019 vtnr Effective Income Tax Rate Reconciliation Paycheck Protection Program Loan Forgiveness
EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramLoanForgiveness
0 USD
CY2021 vtnr Effective Income Tax Rate Reconciliation Noncontrolling Interest
EffectiveIncomeTaxRateReconciliationNoncontrollingInterest
-2247000 USD
CY2020 vtnr Effective Income Tax Rate Reconciliation Noncontrolling Interest
EffectiveIncomeTaxRateReconciliationNoncontrollingInterest
0 USD
CY2019 vtnr Effective Income Tax Rate Reconciliation Noncontrolling Interest
EffectiveIncomeTaxRateReconciliationNoncontrollingInterest
0 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1388000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
0 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
USD
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 USD
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
81000 USD
CY2019 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-643000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1206000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
0 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
862564 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
339000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
403000 USD
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1611000 USD
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1406000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
329000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
120000 USD
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
60000 USD
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
41000 USD
CY2021Q4 vtnr Deferred Tax Assets Acquisition Costs
DeferredTaxAssetsAcquisitionCosts
884000 USD
CY2020Q4 vtnr Deferred Tax Assets Acquisition Costs
DeferredTaxAssetsAcquisitionCosts
0 USD
CY2021Q4 vtnr Deferred Tax Assets Derivative Liability On Convertible Notes
DeferredTaxAssetsDerivativeLiabilityOnConvertibleNotes
18884000 USD
CY2020Q4 vtnr Deferred Tax Assets Derivative Liability On Convertible Notes
DeferredTaxAssetsDerivativeLiabilityOnConvertibleNotes
0 USD
CY2021Q4 vtnr Deferred Tax Assets Disallowed Interest Expense
DeferredTaxAssetsDisallowedInterestExpense
926000 USD
CY2020Q4 vtnr Deferred Tax Assets Disallowed Interest Expense
DeferredTaxAssetsDisallowedInterestExpense
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18609000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15168000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20927000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14357000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
21921000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2781000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2772000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2163000 USD
CY2021Q4 vtnr Deferred Tax Liabilities Discount On Convertible Notes
DeferredTaxLiabilitiesDiscountOnConvertibleNotes
17576000 USD
CY2020Q4 vtnr Deferred Tax Liabilities Discount On Convertible Notes
DeferredTaxLiabilitiesDiscountOnConvertibleNotes
0 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
1573000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Investment In Noncontrolled Affiliates
DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
618000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
21921000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2781000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20927000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
14357000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
656111 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
642840 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3460750 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.05
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3469298 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1150000 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.40
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P8Y9M3D
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
1148662 USD
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
112500 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.46
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
41789 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
80000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.46
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodFairValue
28800 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4418250 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.95
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4547371 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2383625 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.50
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y10M2D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2625779 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2383625 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M2D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2625779 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4418250 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.95
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4547371 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
686038 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.81
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P7Y6M3D
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
355404 USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodFairValue
0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5104288 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M18D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4902775 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3096000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.14
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y5M15D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3110775 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3096000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.14
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y5M15D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3110775 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5104288 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M18D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4902775 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1321240 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.93
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
2066590 USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2041610 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.50
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2140138 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
188750 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.40
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodFairValue
147478 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4195168 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.73
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M13D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4681749 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1716400 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.98
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y11M8D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1707422 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1716400 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.98
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y11M8D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1707422 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2346598 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
219868 shares
CY2018Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
3.01
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P0Y11M4D
CY2018Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
140249 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
1500000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.25
CY2019 vtnr Granted Weighted Average Remaining Contractual Life In Years
GrantedWeightedAverageRemainingContractualLifeInYears
P9Y8M12D
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedGrantDateFairValue
1496372 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2019 vtnr Warrants Exercised Weighted Average Exercise Price
WarrantsExercisedWeightedAverageExercisePrice
0
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedGrantDateFairValue
0 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
219868 shares
CY2019 vtnr Warrants Cancelledforfeitedexpired Weighted Average Exercise Price
WarrantsCancelledforfeitedexpiredWeightedAverageExercisePrice
3.01
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledGrantDateFairValue
140249 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2019Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
3.01
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P0Y11M4D
CY2019Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2019 vtnr Vested Weighted Average Exercise Price
VestedWeightedAverageExercisePrice
0
CY2019 vtnr Vested Weighted Average Remaining Contractual Life In Years
VestedWeightedAverageRemainingContractualLifeInYears
P0Y
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 USD
CY2019Q4 vtnr Warrants Exercisable Shares
WarrantsExercisableShares
0 shares
CY2019Q4 vtnr Warrants Exercisable Weighted Average Exercise Price
WarrantsExercisableWeightedAverageExercisePrice
0
CY2019 vtnr Exercisable Weighted Average Remaining Contractual Life In Years
ExercisableWeightedAverageRemainingContractualLifeInYears
P0Y
CY2019 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantDateFairValue
0 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2019Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
3.01
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P0Y11M4D
CY2019Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
0 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2020 vtnr Granted Weighted Average Remaining Contractual Life In Years
GrantedWeightedAverageRemainingContractualLifeInYears
P0Y
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedGrantDateFairValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2020 vtnr Warrants Exercised Weighted Average Exercise Price
WarrantsExercisedWeightedAverageExercisePrice
0
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedGrantDateFairValue
0 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
0 shares
CY2020 vtnr Warrants Cancelledforfeitedexpired Weighted Average Exercise Price
WarrantsCancelledforfeitedexpiredWeightedAverageExercisePrice
0
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledGrantDateFairValue
0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2020Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
2.25
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P8Y8M12D
CY2020Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2020 vtnr Vested Weighted Average Exercise Price
VestedWeightedAverageExercisePrice
0
CY2020 vtnr Vested Weighted Average Remaining Contractual Life In Years
VestedWeightedAverageRemainingContractualLifeInYears
P0Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 USD
CY2020Q4 vtnr Warrants Exercisable Shares
WarrantsExercisableShares
0 shares
CY2020Q4 vtnr Warrants Exercisable Weighted Average Exercise Price
WarrantsExercisableWeightedAverageExercisePrice
0
CY2020 vtnr Exercisable Weighted Average Remaining Contractual Life In Years
ExercisableWeightedAverageRemainingContractualLifeInYears
P0Y
CY2020 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantDateFairValue
0 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2020Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
2.25
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P8Y8M12D
CY2020Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
0 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedGrantDateFairValue
0 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2021 vtnr Warrants Exercised Weighted Average Exercise Price
WarrantsExercisedWeightedAverageExercisePrice
0
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedGrantDateFairValue
0 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
0 shares
CY2021 vtnr Warrants Cancelledforfeitedexpired Weighted Average Exercise Price
WarrantsCancelledforfeitedexpiredWeightedAverageExercisePrice
0
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledGrantDateFairValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
1500000 shares
CY2021Q4 vtnr Warrants Weighted Average Exercise Price Outstanding
WarrantsWeightedAverageExercisePriceOutstanding
2.25
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P7Y8M12D
CY2021Q4 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantDateFairValue
1496372 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
0 shares
CY2021 vtnr Vested Weighted Average Exercise Price
VestedWeightedAverageExercisePrice
0
CY2021 vtnr Vested Weighted Average Remaining Contractual Life In Years
VestedWeightedAverageRemainingContractualLifeInYears
P0Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 USD
CY2021Q4 vtnr Warrants Exercisable Shares
WarrantsExercisableShares
0 shares
CY2021Q4 vtnr Warrants Exercisable Weighted Average Exercise Price
WarrantsExercisableWeightedAverageExercisePrice
0
CY2021 vtnr Exercisable Weighted Average Remaining Contractual Life In Years
ExercisableWeightedAverageRemainingContractualLifeInYears
P0Y
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantDateFairValue
0 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63287965 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63287965 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45554841 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45554841 shares
CY2021 vtnr Common Stock Voting Rights Numberof Votes
CommonStockVotingRightsNumberofVotes
1 segment
CY2021 vtnr Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Of Warrants
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesOfWarrants
3092912 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 vtnr Preferred Stock Amount Received Prior To Similar Liquidation Payments Per Share
PreferredStockAmountReceivedPriorToSimilarLiquidationPaymentsPerShare
1.49
CY2021 vtnr Preferred Stock Conditionsfor Automatic Common Stock Conversion Minimum Gross Public Offering Amount
PreferredStockConditionsforAutomaticCommonStockConversionMinimumGrossPublicOfferingAmount
10000000 USD
CY2021 vtnr Preferred Stock Conditionsfor Automatic Common Stock Conversion Minimum Proceedsto Shareholdersif Companyis Sold Per Share
PreferredStockConditionsforAutomaticCommonStockConversionMinimumProceedstoShareholdersifCompanyisSoldPerShare
10.00
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1 shares
CY2015Q2 vtnr Preferred Stock Termsof Conversion Beneficial Conversion Feature
PreferredStockTermsofConversionBeneficialConversionFeature
5737796 USD
CY2020Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
330412 USD
CY2016Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1.56
CY2017Q2 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1.72
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
330412 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1969216 USD
CY2021 vtnr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Value Of Warrants Exercised
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValueOfWarrantsExercised
11673663 USD
CY2020 vtnr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Value Of Warrants Exercised
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValueOfWarrantsExercised
0 USD
CY2021 vtnr Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Changein Valuation
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityChangeinValuation
11343251 USD
CY2020 vtnr Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Changein Valuation
FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityChangeinValuation
-1638804 USD
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
330412 USD
CY2021Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
95980 USD
CY2020Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-94214 USD
CY2021 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-2257592 USD
CY2020 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
3476593 USD
CY2019 us-gaap Gain Loss On Sale Of Commodity Contracts
GainLossOnSaleOfCommodityContracts
-2458359 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115781375 USD
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
110720368 USD
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
486428 USD
CY2021 us-gaap Gross Profit
GrossProfit
4574579 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17732690 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2123703 USD
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
107664 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-15389478 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47019043 USD
CY2020 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
45520114 USD
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
458155 USD
CY2020 us-gaap Gross Profit
GrossProfit
1040774 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8117429 USD
CY2020 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
71776 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-7148431 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18357575 USD
CY2019 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
16952135 USD
CY2019 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
461110 USD
CY2019 us-gaap Gross Profit
GrossProfit
944330 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6657178 USD
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
0 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-5712848 USD
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3620 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
4344 USD
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
4344 USD
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
50093 USD
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
51618 USD
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
22477 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
860000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
800000 USD
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
902712 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
900000 USD
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
586612 USD
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
226431 USD
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
79790 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
959573 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
895518 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
783036 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
722924 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
702824 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3681426 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7745301 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2733850 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5011451 USD
CY2021 vtnr Lessee Operating Lease Number Of Renewal Options
LesseeOperatingLeaseNumberOfRenewalOptions
2 option

Files In Submission

Name View Source Status
0001628280-22-005958-index-headers.html Edgar Link pending
0001628280-22-005958-index.html Edgar Link pending
0001628280-22-005958.txt Edgar Link pending
0001628280-22-005958-xbrl.zip Edgar Link pending
a12312021-ex101.htm Edgar Link pending
a12312021-ex1015.htm Edgar Link pending
a12312021-ex1016.htm Edgar Link pending
a12312021-ex1017.htm Edgar Link pending
a12312021-ex1021.htm Edgar Link pending
a12312021-ex211.htm Edgar Link pending
a12312021-ex231.htm Edgar Link pending
a12312021-ex311.htm Edgar Link pending
a12312021-ex312.htm Edgar Link pending
a12312021-ex321.htm Edgar Link pending
a12312021-ex322.htm Edgar Link pending
a12312021-ex41.htm Edgar Link pending
a123121-ex1013.htm Edgar Link pending
a32.jpg Edgar Link pending
certificateofcorrectionpac.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_01a.jpg Edgar Link pending
image_02a.jpg Edgar Link pending
image_03.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_11a.jpg Edgar Link pending
image_1a.jpg Edgar Link pending
image_2a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtnr-20211231.htm Edgar Link pending
vtnr-20211231.xsd Edgar Link pending
vtnr-20211231_cal.xml Edgar Link unprocessable
vtnr-20211231_def.xml Edgar Link unprocessable
vtnr-20211231_g1.jpg Edgar Link pending
vtnr-20211231_g2.jpg Edgar Link pending
vtnr-20211231_g3.jpg Edgar Link pending
vtnr-20211231_htm.xml Edgar Link completed
vtnr-20211231_lab.xml Edgar Link unprocessable
vtnr-20211231_pre.xml Edgar Link unprocessable